Does enhanced recovery after surgery programs improve clinical outcomes in liver cancer surgery?

Belinda Sánchez-Pérez,José M Ramia
DOI: https://doi.org/10.4251/wjgo.v16.i2.255
2024-02-03
World Journal of Gastrointestinal Oncology
Abstract:Enhanced recovery after surgery (ERAS) programs have been widely applied in liver surgery since the publication of the first ERAS guidelines in 2016 and the new recommendations in 2022. Liver surgery is usually performed in oncological patients (liver metastasis, hepatocellular carcinoma, cholangiocarcinoma, etc. ), but the real impact of liver surgery ERAS programs in oncological outcomes is not clearly defined. Theoretical advantages of ERAS programs are: ERAS decreases postoperative complication rates and has been demonstrated a clear relationship between complications and oncological outcomes; a better and faster postoperative recovery should let oncologic teams begin chemotherapeutic regimens on time; prehabilitation and nutrition actions before surgery should also improve the performance status of the patients receiving chemotherapy. So, ERAS could be another way to improve our oncological results. We will discuss the literature about liver surgery ERAS focusing on its oncological implications and future investigations projects.
oncology,gastroenterology & hepatology
What problem does this paper attempt to address?